Published in J Physiol on April 01, 1977
Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol (1980) 1.78
Synaptic delay in the heart: an ionophoretic study. J Physiol (1978) 1.74
Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate. Br J Pharmacol (1978) 1.17
Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol (1980) 1.07
Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br J Pharmacol (1980) 0.95
The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid. Br J Pharmacol (1981) 0.88
Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc Natl Acad Sci U S A (1982) 0.86
4-Aminopyridine blockade of neuronal depressant responses to adenosine triphosphate. Br J Pharmacol (1980) 0.85
Characteristics of the release of adenosine from slices of rat cerebral cortex. J Physiol (1980) 0.84
Vasoactive intestinal polypeptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons. Proc Natl Acad Sci U S A (1985) 0.77
Influence of cerebral embolism on brain monoamines. J Neurol Neurosurg Psychiatry (1979) 0.75
The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol (1970) 5.15
Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl (1971) 4.49
The role of cyclic-3',5'-AMP in responses to catecholamines and other hormones. Pharmacol Rev (1966) 3.89
Cyclic GMP. Adv Cyclic Nucleotide Res (1973) 2.52
Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain. J Biol Chem (1972) 2.35
Pharmacological studies on feline Betz cells. J Physiol (1966) 2.11
Acetylcholine-sensitive cells in the cerebral cortex. J Physiol (1963) 1.97
The role of cyclic nucleotides in central synaptic function. Rev Physiol Biochem Pharmacol (1975) 1.66
Role of muscarinic cholinergic receptors in regulation of guanosine 3':5'-cyclic monophosphate content in mammalian brain, heart muscle, and intestinal smooth muscle. Proc Natl Acad Sci U S A (1972) 1.66
Studies on adenosine 3',5'-phosphate in rabbit cerebral cortex. Mol Pharmacol (1968) 1.65
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis. Brain Res (1971) 1.55
Guanosine 3',5'-monophosphate in sympathetic ganglia: increase assoicated with synaptic transmission. Science (1974) 1.48
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. 3. Evidence for mediation of norepinephrine effects by cyclic 3',5'-adenosine monophosphate. Brain Res (1971) 1.36
The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies. Brain Res (1974) 1.31
Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar Purkinje cells. Science (1969) 1.26
The effect of tricyclic antidepressants on cholinergic responses of single cortical neurones. Br J Pharmacol (1975) 1.12
To spritz or not to spritz: the doubtful value of aimless iontophoresis. Life Sci (1974) 1.08
Micromethods in neuropharmacology: an approach to the study of anesthetics. Anesthesiology (1967) 1.08
Cholinergic mechanisms in the rat somatosensory cerebral cortex. J Physiol (1972) 1.07
Adenosine-dependent formation of cyclic AMP in brain slices. Pharmacol Res Commun (1976) 1.07
Proceedings: Regulation of the cyclic AMP concentration in chick brain by beta-adrenoreceptors and histamine H2 receptors. Br J Pharmacol (1974) 1.03
Depression of corticospinal cells by various purines and pyrimidines. Can J Physiol Pharmacol (1974) 1.01
Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cells. Science (1971) 1.01
Cortical responses to pyramidal tract stimulation in the rat. Exp Neurol (1972) 1.00
A quantitative microiontophoretic analysis of the responses of central neurones to noradrenaline: interactions with cobalt, manganese, verapamil and dichloroisoprenaline. Br J Pharmacol (1975) 0.98
Action of various adenine derivatives on cerebellar Purkinje cells. Brain Res (1975) 0.97
Neurohumoral mechanisms in the brain slice. Adv Pharmacol Chemother (1970) 0.97
Characteristics of the release of adenosine 3':5'-monophosphate from micropipets by microiontophoresis. J Cyclic Nucleotide Res (1975) 0.97
The regulation of cyclic guanosine monophosphate in rat cerebellum: possible involvement of putative amino acid neurotransmitters. Brain Res (1974) 0.95
Mechanism of noradrenaline action in cat cerebral cortex. Nat New Biol (1972) 0.94
Regulation of cyclic adenosine 3',5'-monophosphate levels in guinea-pig cerebral cortex by interaction of alpha adrenergic and adenosine receptor activity. J Pharmacol Exp Ther (1975) 0.91
Comparison of the effects of depolarizing agents and neurotransmitters on regional CNS cyclic GMP levels in various animals. J Neurochem (1976) 0.88
Neurohormones on brain adenyl cyclase activity in vivo. Nat New Biol (1971) 0.88
Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63 197). J Pharm Pharmacol (1973) 0.88
Interpreting the failures to confirm the depression of cerebellar Purkinje cells by cyclic AMP. Science (1974) 0.87
Effect of phenothiazine neuroleptic drugs and tricyclic antidepressants on phosphodiesterase activity in rat cerebral cortex. Psychopharmacologia (1974) 0.87
Adenosine as a putative transmitter in the cerebral cortex. Studies with potentiators and antagonists. Life Sci (1975) 0.86
Is cyclic guanosine monophosphate the internal 'second messenger' for cholinergic actions on central neurons? Can J Physiol Pharmacol (1976) 0.86
Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellum. Biochem Biophys Res Commun (1972) 0.85
Cyclic AMP mediation of norepinephrine inhibition in rat cerebellar cortex: a unique class of synaptic responses. Ann N Y Acad Sci (1971) 0.81
Electrophysiology of Purkinje neurons in the weaver mouse: iontophoresis of neurotransmitters and cyclic nucleotides, and stimulation of the nucleus locus coeruleus. Brain Res (1976) 0.81
Pharmacology of pyramidal tract cells in the cerebral cortex. Noradrenaline and related substances. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.80
Comparison of effects of noradrenaline and histamine with cyclic AMP on brain stem neurones. Brain Res (1973) 0.80
Failure to confirm cyclic AMP as second messenger for norepinephrine in rat cerebellum. Science (1974) 0.80
Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons. Life Sci (1974) 0.79
Responses of identified cerebral cortical neurones to cyclic GMP and cyclic AMP. J Physiol (1975) 0.77
Cyclic adenosine monophosphate and norepinephrine: effect on purkinje cells in rat cerebellar cortex. Science (1971) 0.76
Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation (2001) 3.89
An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res (1982) 2.99
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol (2001) 2.07
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol (1981) 2.02
Microtubules in hamster platelets. J Cell Biol (1965) 1.89
Physiological roles for adenosine and adenosine 5'-triphosphate in the nervous system. Neuroscience (1981) 1.85
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med (1997) 1.84
Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys (1999) 1.72
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature (1981) 1.50
Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol (1989) 1.46
Increased kynurenic acid levels in Huntington's disease. Lancet (1988) 1.43
A new crop of concerns: Congress investigates pesticide safety. Environ Health Perspect (2000) 1.39
Classification of pain following spinal cord injury. Spinal Cord (1997) 1.38
Quinolinic acid and other kynurenines in the central nervous system. Neuroscience (1985) 1.34
Efflux characteristics of isotopically labelled gamma-aminobutyric acid (GABA) and L-glutamate in the rat cuneate nucleus [proceedings]. Br J Pharmacol (1977) 1.32
Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem (2005) 1.31
Serial lumbar punctures for at least temporary amelioration of neonatal posthemorrhagic hydrocephalus. Pediatrics (1985) 1.29
Pain report and the relationship of pain to physical factors in the first 6 months following spinal cord injury. Pain (1999) 1.27
Electron probe analysis of human skin: determination of the water concentration profile. J Invest Dermatol (1988) 1.26
The cuing and priming of cognitive operations. J Exp Psychol Hum Percept Perform (1987) 1.24
The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels (1985) 1.23
Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J Pharmacol Exp Ther (1983) 1.19
Cellular cardiomyoplasty improves diastolic properties of injured heart. J Surg Res (1999) 1.19
Cortical pyramidal tract interneurones and their sensitivity to L-glutamic acid. J Physiol (1973) 1.18
Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate. Br J Pharmacol (1978) 1.17
Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol (1995) 1.15
Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant (2000) 1.13
Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br J Nutr (2001) 1.13
Biatrial myxoma: a rare cardiac tumor. Ann Thorac Surg (1998) 1.11
Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol (2006) 1.08
Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia caeci and bladder. Eur J Pharmacol (1981) 1.08
Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br J Pharmacol (1999) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol (1980) 1.07
Cholinergic mechanisms in the rat somatosensory cerebral cortex. J Physiol (1972) 1.07
Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol (1998) 1.07
Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci (2007) 1.05
The effect of reserpine treatment on the chronotropic and inotropic sensitivities of the perfused guinea-pig heart to norepinephrine and calcium. Eur J Pharmacol (1974) 1.04
Glutamate as the neurotransmitter of cerebellar granule cells in the rat: electrophysiological evidence. Br J Pharmacol (1979) 1.03
Spontaneous regression of pulmonary metastases following palliative nephrectomy. Case report. Cancer (1967) 1.03
Benzodiazepines and central inhibitory mechanisms. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.03
Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine. Br J Pharmacol (1976) 1.02
Phosphonate analogues of carboxylic acids as aminoacid antagonists on rat cortical neurones. Neurosci Lett (1981) 1.02
Quinolinic acid: regional variations in neuronal sensitivity. Brain Res (1983) 1.02
Amino acid pharmacology in neocortical slices: evidence for bimolecular actions from an extension of the Hill and Gaddum-Schild equations. Br J Pharmacol (1988) 1.02
Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol (1999) 1.01
A DNA analysis program designed for computer novices working in an industrial-research environment. Nucleic Acids Res (1984) 1.01
Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results. Acta Cytol (1998) 1.01
Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists. Neuroscience (1998) 1.00
Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br J Pharmacol (1993) 1.00
Purine receptors in the rat anococcygeus muscle. J Physiol (1983) 1.00
Cortical responses to pyramidal tract stimulation in the rat. Exp Neurol (1972) 1.00
Blockade by amino acid antagonists of neuronal excitation mediated by the pyramidal tract. J Physiol (1976) 1.00
Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus. Brain Res (1996) 0.98
Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat. J Pharmacol Exp Ther (1994) 0.98
Adenine dinucleotide effects on rat cortical neurones. Brain Res (1981) 0.98
Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat. Neuropharmacology (1983) 0.97
Are noradrenaline excitations artefacts? Nature (1971) 0.97
Cell-based cardiovascular repair--the hurdles and the opportunities. Basic Res Cardiol (2005) 0.97
Amino acids as neurotransmitters of corticofugal neurones in the rat: a comparison of glutamate and aspartate. Br J Pharmacol (1979) 0.97
Tryptophan loading induces oxidative stress. Free Radic Res (2004) 0.96
Comparison of the effects of ethylenediamine analogues and gamma-aminobutyric acid on cortical and pallidal neurones. Br J Pharmacol (1982) 0.96
Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br J Pharmacol (1980) 0.95
Activation of Rho GTPases by synaptic transmission in the hippocampus. J Neurochem (2003) 0.94
Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat. Eur J Pharmacol (1977) 0.94
Neuronal responses to ethylenediamine: preferential blockade by bicuculline. Neurosci Lett (1981) 0.93
Ethylenediamine as a specific releasing agent of gamma-aminobutyric acid in rat striatal slices. J Neurochem (1982) 0.93
Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library. Biochem Biophys Res Commun (1994) 0.93
Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia. Am J Physiol Heart Circ Physiol (2000) 0.93
Neuronal responses to extracellularly applied cyclic AMP:Role of the adenosine receptor. Experientia (1978) 0.93
Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br J Pharmacol (1998) 0.93
Evidence for sequence-specific conformational changes in DNA from the melting temperatures of DNA phosphorothioate derivatives. Nucleic Acids Res (1985) 0.93
Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro. Eur J Pharmacol (1998) 0.93
Adult patients' knowledge about their congenital heart disease. Can J Cardiol (1997) 0.93
A quantitative pharmacological analysis of some excitatory amino acid receptors in the mouse neocortex in vitro. Br J Pharmacol (1988) 0.92
Extraskeletal Ewing's sarcoma. Diagnosis of a case by fine needle aspiration cytology. Acta Cytol (1987) 0.92
Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann Neurol (1982) 0.91
The effect of theophylline on essential tremor: the possible role of GABA. Pharmacol Biochem Behav (1991) 0.91
Pharmacological characterization of purinergic receptors in the rat vas deferens. J Pharmacol Exp Ther (1983) 0.91
Effect of changing extracellular levels of magnesium on spontaneous activity and glutamate release in the mouse neocortical slice. Br J Pharmacol (1989) 0.90
The activity of phosphorothioate analogues of ATP in various smooth muscle systems. Br J Pharmacol (1985) 0.90
The role of kynurenines in diabetes mellitus. Med Hypotheses (1985) 0.90
Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol (1995) 0.90
The effect of high-intensity rowing and combined strength and endurance training on left ventricular systolic function and morphology. Int J Sports Med (2007) 0.90
Isomers of 2-amino-7-phosphonoheptanoic acid as antagonists of neuronal excitants. Neurosci Lett (1982) 0.90
Competitive antagonism of alpha 1-adrenoceptor mediated pressor responses in the rat mesenteric artery. J Pharm Pharmacol (1984) 0.89
Sex-based differences in vascular repair with bone marrow cell therapy: relevance of regulatory and Th2-type cytokines. Transplant Proc (2008) 0.89
Cardiac tamponade as the first clinical manifestation of metastatic adenocarcinoma of the lung. Can J Cardiol (2000) 0.89
Effects of dexamethasone on late radiation injury following partial-body and local organ exposures. Radiat Res (1992) 0.89
Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology (Berl) (1996) 0.89
Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia. Brain Res (2001) 0.89
Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex. Science (1975) 0.89
Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res (1998) 0.89
Pigmented pheochromocytomas of the adrenal medulla. Hum Pathol (1993) 0.88
An electrophysiological demonstration of a synergistic interaction between norepinephrine and adenosine in the cerebral cortex. Brain Res (1978) 0.88
The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures. Br J Pharmacol (1977) 0.88
Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res (2003) 0.88